PG vs TTRX · P/E 25, rev $84.28B vs $187.1M cap
Procter & Gamble Company (PG) versus Turn Therapeutics Inc. Common Stock (TTRX) — a side-by-side from cached financials, not a winner call.
Procter & Gamble Company (PG) is a household & personal products company listed on US. It is led by Jon Moeller.
Turn Therapeutics Inc. Common Stock (TTRX) is a biotechnology company listed on NASDAQ.
Latest reported PG revenue for 2025-06-30 was $84.28B. Net income was $15.97B. PG currently screens at market cap $373.53B and trailing P/E 25.3.
TTRX does not have a complete income-statement cache yet.
PG currently screens at market cap $373.53B and trailing P/E 25.3. TTRX currently screens at market cap $187.1M.
Not investment advice. Open the PG and TTRX stock pages for the full models.
Not investment advice.